These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
322 related articles for article (PubMed ID: 34708593)
41. A Low-Cost HPV Immunochromatographic Assay to Detect High-Grade Cervical Intraepithelial Neoplasia. Mariano VS; Lorenzi AT; Scapulatempo-Neto C; Stein MD; Resende JC; Antoniazzi M; Villa LL; Levi JE; Longatto-Filho A; Fregnani JH PLoS One; 2016; 11(10):e0164892. PubMed ID: 27764154 [TBL] [Abstract][Full Text] [Related]
42. Evaluation of 14 triage strategies for HPV DNA-positive women in population-based cervical screening. Rijkaart DC; Berkhof J; van Kemenade FJ; Coupe VM; Hesselink AT; Rozendaal L; Heideman DA; Verheijen RH; Bulk S; Verweij WM; Snijders PJ; Meijer CJ Int J Cancer; 2012 Feb; 130(3):602-10. PubMed ID: 21400507 [TBL] [Abstract][Full Text] [Related]
43. Approaches to triage optimization in HPV primary screening: Extended genotyping and p16/Ki-67 dual-stained cytology-Retrospective insights from ATHENA. Stoler MH; Baker E; Boyle S; Aslam S; Ridder R; Huh WK; Wright TC Int J Cancer; 2020 May; 146(9):2599-2607. PubMed ID: 31490545 [TBL] [Abstract][Full Text] [Related]
44. Clinical evaluation of human papillomavirus 16/18 oncoprotein test for cervical cancer screening and HPV positive women triage. Yu L; Jiang M; Qu P; Wu Z; Sun P; Xi M; Qin Y; Liu X; Liao G; Lei X; Sun L; Zhang Y; Li Z; Chen W; Qiao YL Int J Cancer; 2018 Aug; 143(4):813-822. PubMed ID: 29524206 [TBL] [Abstract][Full Text] [Related]
45. HPV16/18 genotyping for the triage of HPV positive women in primary cervical cancer screening in Chile. Lagos M; Van De Wyngard V; Poggi H; Cook P; Viviani P; Barriga MI; Pruyas M; Ferreccio C Infect Agent Cancer; 2015; 10():43. PubMed ID: 26600869 [TBL] [Abstract][Full Text] [Related]
46. Diagnostic value of high-risk HPV other than type 16/18 in high-grade cervical neoplasia among cytology-negative women: A multicenter retrospective study. Bai A; Xue P; Li Q; Jiang Y; Qiao Y Cancer Med; 2023 Jul; 12(13):14794-14805. PubMed ID: 37199394 [TBL] [Abstract][Full Text] [Related]
47. Clinical Evaluation of Human Papillomavirus Screening With p16/Ki-67 Dual Stain Triage in a Large Organized Cervical Cancer Screening Program. Wentzensen N; Clarke MA; Bremer R; Poitras N; Tokugawa D; Goldhoff PE; Castle PE; Schiffman M; Kingery JD; Grewal KK; Locke A; Kinney W; Lorey TS JAMA Intern Med; 2019 Jul; 179(7):881-888. PubMed ID: 31081870 [TBL] [Abstract][Full Text] [Related]
48. DNA methylation marker for the triage of hrHPV positive women in cervical cancer screening: Real-world evidence in Taiwan. Chang CL; Ho SC; Su YF; Juan YC; Huang CY; Chao AS; Hsu ZS; Chang CF; Fwu CW; Chang TC Gynecol Oncol; 2021 May; 161(2):429-435. PubMed ID: 33757653 [TBL] [Abstract][Full Text] [Related]
49. HPV genotyping for triage of women with abnormal cervical cancer screening results: a multicenter prospective study. Nakamura Y; Matsumoto K; Satoh T; Nishide K; Nozue A; Shimabukuro K; Endo S; Nagai K; Oki A; Ochi H; Morishita Y; Noguchi M; Yoshikawa H Int J Clin Oncol; 2015 Oct; 20(5):974-81. PubMed ID: 25652908 [TBL] [Abstract][Full Text] [Related]
50. Genotyping and Cytology Triage of High-Risk HPV DNA Positive Women for Detection of Cervical High-Grade Lesions. El-Zein M; Bouten S; Abdrabo LS; Siblini A; Louvanto K; Franco E; Ferenczy A J Low Genit Tract Dis; 2023 Jan; 27(1):12-18. PubMed ID: 36205321 [TBL] [Abstract][Full Text] [Related]
51. Accuracy of genotyping for HPV16 and 18 to triage women with low-grade squamous intraepithelial lesions: a pooled analysis of VALGENT studies. Xu L; Benoy I; Cuschieri K; Poljak M; Bonde J; Arbyn M Expert Rev Mol Diagn; 2019 Jun; 19(6):543-551. PubMed ID: 31035813 [No Abstract] [Full Text] [Related]
52. Efficacy of optical coherence tomography in the triage of women with minor abnormal cervical cytology before colposcopy. Yan L; Xiao X; He L; Shi L; Yang X; Zhang J; Zhang Y; Fu C PLoS One; 2023; 18(3):e0282833. PubMed ID: 36913396 [TBL] [Abstract][Full Text] [Related]
53. Triaging women with human papillomavirus infection and normal cytology or low-grade dyskaryosis: evidence from 10-year follow up of the ARTISTIC trial cohort. Gilham C; Sargent A; Peto J BJOG; 2020 Jan; 127(1):58-68. PubMed ID: 31541495 [TBL] [Abstract][Full Text] [Related]
54. Assessment of the effectiveness of HPV16/18 infection referred for colposcopy in cervical cancer screening in Northwest of China. Zhang Q; Zhao M; Cao D; Wei X; Wang L; Li Y; Yang T; Zhao J; Pei M; Jia H; Cao S; Quan S; Yang X J Med Virol; 2018 Jan; 90(1):165-171. PubMed ID: 28710863 [TBL] [Abstract][Full Text] [Related]
55. The clinical value of HPV genotyping in triage of women with high-risk-HPV-positive self-samples. Ebisch RM; de Kuyper-de Ridder GM; Bosgraaf RP; Massuger LF; IntHout J; Verhoef VM; Heideman DA; Snijders PJ; Meijer CJ; van Kemenade FJ; Bulten J; Siebers AG; Bekkers RL; Melchers WJ Int J Cancer; 2016 Aug; 139(3):691-9. PubMed ID: 26991464 [TBL] [Abstract][Full Text] [Related]
56. Clinical validation of p16/Ki-67 dual-stained cytology triage of HPV-positive women: Results from the IMPACT trial. Wright TC; Stoler MH; Ranger-Moore J; Fang Q; Volkir P; Safaeian M; Ridder R Int J Cancer; 2022 Feb; 150(3):461-471. PubMed ID: 34536311 [TBL] [Abstract][Full Text] [Related]
57. Clinical Performance of hrHPV Primary Screening Using Vaginal versus Cervical Samples to Detect High-grade Intraepithelial Lesions. King J; Flores YN; Meneses-León J; Hernández-Salazar S; Robles-Rivera K; Rivera-Paredez B; León-Maldonado L; Hernández-López R; Torres-Ibarra L; Lazcano-Ponce E; Salmerón J Cancer Prev Res (Phila); 2023 Dec; 16(12):681-687. PubMed ID: 37788346 [TBL] [Abstract][Full Text] [Related]
58. Clinical Performance of Triage Strategies for Hr-HPV-Positive Women; A Longitudinal Evaluation of Cytology, p16/K-67 Dual Stain Cytology, and HPV16/18 Genotyping. Stanczuk G; Currie H; Forson W; Baxter G; Lawrence J; Wilson A; Palmer T; Arbyn M; Cuschieri K Cancer Epidemiol Biomarkers Prev; 2022 Jul; 31(7):1492-1498. PubMed ID: 35511738 [TBL] [Abstract][Full Text] [Related]
59. The WID-CIN test identifies women with, and at risk of, cervical intraepithelial neoplasia grade 3 and invasive cervical cancer. Barrett JE; Sundström K; Jones A; Evans I; Wang J; Herzog C; Dillner J; Widschwendter M Genome Med; 2022 Oct; 14(1):116. PubMed ID: 36258199 [TBL] [Abstract][Full Text] [Related]